Neurology - Page 4

Registered on ClinicalTrials

The results of a multicenter dual blind randomized placebo-controlled clinical study on the assessment of the effectiveness and safety of the drug Mexidol in the treatment of attention deficit syndrome in children (mega)

The results of an international multicenter randomized double-blind-controlled study of evaluating the effectiveness of the effectiveness and safety of consistent therapy of patients with chronic brain ischemia with Mexidol and Mexidol Forte 250 (study of Memo)

The results of a randomized double blind multicenter placebo-controlled in parallel groups of the study and safety of Mexidol with prolonged consistent therapy in patients in the acute and early recovery periods

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

The results of a cohort -center randomized study of the modulating effect of Mexidol® in the rehabilitation of patients who have undergone acute cerebral failure

The value of mitochondrial dysfunction in stabilization

Vascular depression and cognitive dysfunction

Author:

Bogolepova A.N.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2019

The study of the effectiveness and safety of the use of Mexidol and Mexidol Forte 250 in patients with chronic brain ischemia

Author:
V.A. Kutashov, O.V. Ulyanova

FSBEI in Voronezh State Medical University named after N.N. Burdenko »Ministry of Health of Russia, Voronezh, Russia

The effectiveness and safety of the drug Mexol Forte 250 in the framework of consecutive therapy in patients with chronic brain ischemia

Author:
E.I. Chukanova, A.S. Chukanova

Department of Neurology, Neurosurgery and Medical Genetics of Faculty of Faculty of Faculty of FSBEI in "RNIMU named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

Review of clinical recommendations for the treatment and prevention of ischemic stroke

Author:
A.I. Fedin, K.R. Badalyan

FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia

The prospects for the use of Mexidol for the treatment of patients suffering from neurosenate hearing loss and cerebrovascular failure

Author:
N.L. Kunelskaya, Yu.V. Levina, E.S. Yanyushkina, D.S. Ogorodnikov, E.V. Larionova

Combined use of Mexidol with well -known drugs

Author:
T.A. Voronina, E.A. Ivanova

FGBNU "Research Institute of Pharmacology named after V.V. Zakusova ”, Moscow, Russia

Assessment of rheological indicators of blood in patients with acute ischemic stroke when using the drug Mexidol

Authors:

D.M. Plotnikov ¹ , M.N. Stegmeier ¹ , O.I. Aliyev ²

¹ Department of Neurology and Neurosurgery of the Federal State Budgetary Institution “Siberian State Medical University” of the Ministry of Health of Russia, Tomsk, Russia;
² research institute pharmacology and regenerative therapy named after E.D. Goldberg Tomsk Nimets of the Russian Academy of Sciences, Tomsk, Russia

The dynamics of cognitive functions in aging and their connection with the level of education

Authors:

Titarenko A.V., Shishkin S.V., Shcherbakova L.V., Verevkin E.G., Holmes M., Bobak M., Malyutina S.K.

Place of publication:

Neurology, neuropsychiatry, psychosomatics. 2018

Brainstorm, or Cognitive disorders

Authors:
V.V. Zakharov, E.Yu. Kalimeeva, N.V. Vakhnin, T.G. Fateeva

Department of Nervous Diseases and Neurosurgery of the First MGMU named after THEM. Sechenova, Moscow

The effect of the use of Mexidol during the "therapeutic window" of ischemic stroke on the effectiveness of intravenous thrombolytic therapy

Authors:
K.S. Knny, T.V. Demin, L.B. Adaeva

GAUZ "Interregional Clinical and Diagnostic Center", Kazan, Russia

The effect of Mexidol on changes in lipid phospholipid profile in acute cerebrovascular disorders in elderly patients

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

The experience of using Mexidol in neurological practice

Authors:

O.A. Gromova ¹ , I.Yu. Torshin ¹ , L.V. Stakhovskaya ² , E.G. Pepelyaev ³ , V.A. Semenov ³ , A.G. Nazarenko ⁴

¹ Institute of Pharmacinformatics of the FIC "Informatics and management" of the Russian Academy of Sciences, Moscow, Russia;
² Research Institute of Cerebrovascular Pathology and Stroke FSBEI in Russian National Research Medical University named after N.I. Pirogov »Ministry of Health of Russia, Moscow, Russia;
³ FSBEI in Kemerovo State Medical University of the Ministry of Health of Russia, Kemerovo, Russia;
⁴ FGAU "National Medical Research Center for Neurosurgery named after Acad. N.N. Burdenko »Ministry of Health of Russia, Moscow, Russia

The effectiveness of Mexidol with transient ischemic attacks in the vertebral-baslar system in elderly patients with chronic brain ischemia

Author:
Yu.V. Abramenko

FSBEI in the Tver State Medical University of the Ministry of Health of Russia, Tver, Russia

Mexicular and combined therapy with Mexidol with young patients with cerebral angiodistonia

Authors:
E.N. Dyakonova, V.V. Makerova

FSBEI in "Ivanovo State Medical Academy" of the Ministry of Health of Russia, Ivanovo, Russia

Increasing the effectiveness of the treatment of hypertensive encephalopathy with the drug Mexidol

Authors:
E.V. Bolotova ¹ , T.Yu. Lushpai ² , I.V. Kovrigina ²

¹ FSBEI in Kuban State Medical University of the Ministry of Health of Russia, Krasnodar, Russia;
² GBUZ "Research Institute - Regional Clinical Hospital No. 1 named after Prof. S.V. Ochapovsky "of the Ministry of Health of the Krasnodar Territory, Krasnodar, Russia

The effect of submaximal doses of the drug Mexidol on the processes of oxidant stress and inflammation in the acute period of ischemic stroke

Authors:
A.R. Godunova, A.A. Rakhimova, O.I. Leontyeva, I.G. Talipova, R.M. Yakhin, Sh.G. Musin

GBUZ of the Republic of Tatarstan "Hospital of ambulance", Naberezhnye Chelny, Russia

« 1 2 3 4 5 6 »